GTHX — G1 Therapeutics Cashflow Statement
0.000.00%
Last trade - 00:00- $208.28m
- $177.68m
- $82.51m
- 61
- 20
- 86
- 56
Annual cashflow statement for G1 Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -122 | -99.3 | -148 | -148 | -48 |
| Depreciation | |||||
| Non-Cash Items | 16.4 | 19 | 24.6 | 23.7 | 14.3 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 6.07 | -4.08 | -8.84 | -5.31 | -5.2 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -99.6 | -83.7 | -132 | -129 | -38.3 |
| Capital Expenditures | -2.72 | — | 0 | -0.506 | 0 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | — | 0.152 | 0 | -50 | 2.81 |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Cash from Investing Activities | -2.72 | 0.152 | 0 | -50.5 | 2.81 |
| Financing Cash Flow Items | 0 | -0.62 | -1.41 | -0.043 | -0.281 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 2.71 | 21.7 | 146 | 52.5 | -26.9 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -99.6 | -61.9 | 13.8 | -127 | -62.4 |